UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group

Annals of oncology, 2004-12, Vol.15 (12), p.1816-1824

2004

Volltextzugriff (PDF)

Weekly 24 h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours

European journal of cancer (1990), 2005-07, Vol.41 (10), p.1431-1438

2005

Volltextzugriff (PDF)

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity

British journal of cancer, 1996-12, Vol.74 (12), p.2036-2041

1996

Volltextzugriff (PDF)

Cisplatin nephrotoxicity and protection by silibinin

Nephrology, dialysis, transplantation, 1996, Vol.11 (1), p.55-62

1996

Volltextzugriff (PDF)

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

European journal of cancer (1990), 2008-08, Vol.44 (12), p.1657-1662

2008

Volltextzugriff (PDF)

Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues

Biochemistry (Easton), 2004-03, Vol.43 (11), p.2996-3007

2004

Volltextzugriff (PDF)

Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific Lectin from Viscum album plant extract

Phytomedicine (Stuttgart), 1996-09, Vol.3 (2), p.129-137

1996

Volltextzugriff (PDF)

Complex regulation of human neutrophil activation by actin filaments: dihydrocytochalasin B and botulinum C2 toxin uncover the existence of multiple cation entry pathways

Journal of leukocyte biology, 1997-06, Vol.61 (6), p.703-711

1997

Volltextzugriff (PDF)

A phase II multicenter study on CY-503 in the treatment of patients with unresectable stage IV metastatic melanoma after failure of previous chemotherapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e19015-e19015

2010

Volltextzugriff (PDF)

Concanavalin A and mistletoe lectin I differentially activate cation entry and exocytosis in human neutrophils: lectins may activate multiple subtypes of cation channels

Journal of leukocyte biology, 1996-09, Vol.60 (3), p.345-355

1996

Volltextzugriff (PDF)

A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells

Natural immunity, 1995-01, Vol.14 (5-6), p.295

1995

Volltextzugriff (PDF)

P24. Aviscumine enhances NK- cytotoxicity against tumor cells

Journal for immunotherapy of cancer, 2014-03, Vol.2 (S2), p.P15-P15, Article P15

2014

Volltextzugriff (PDF)

Cisplatin nephrotoxicity and protection by silibinin

Nephrology, dialysis, transplantation, 1996-01, Vol.11 (1), p.55-62

1996

Volltextzugriff (PDF)

Site-Specific Mutagenesis of Mistletoe Lectin: The Role of RIP Activity in Apoptosis

Biochemical and biophysical research communications, 1999-11, Vol.264 (3), p.944-948

1999

Volltextzugriff (PDF)

Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro

Cancer detection and prevention, 1999-01, Vol.23 (6), p.511-523

1999

Volltextzugriff (PDF)

Phase I evaluation of the weekly 24 hour intravenous administration of aviscumine, a recombinant ribosome-inactivating protein, in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3106-3106

2004

Volltextzugriff (PDF)

Phase I evaluation of the weekly 24 hour intravenous administration of aviscumine, a recombinant ribosome-inactivating protein, in patients with refractory solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3106-3106

2004

Volltextzugriff (PDF)

Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours

European journal of cancer (1990), 2005-07, Vol.41 (10), p.1431-1438

2005

Volltextzugriff (PDF)

In Vitro Efficacy of Conjugates of Anti-CD45 Monoclonal Antibodies With Plant Toxin A-Chains

Transplantation proceedings, 1998-06, Vol.30 (4), p.971-973

1998

Volltextzugriff (PDF)

Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice

Anticancer research, 2001-11, Vol.21 (6A), p.3981

2001

Volltextzugriff (PDF)

Phagocytotic activity of glial cells in culture

Experimental cell research, 1982-01, Vol.142 (2), p.437-445

1982

Volltextzugriff (PDF)

Characterization of recombinant and plant-derived mistletoe lectin and their B-chains

European journal of biochemistry, 1999-10, Vol.265 (2), p.788-797

1999

Volltextzugriff (PDF)

Mistletoe lectin I forms a double trefoil structure

FEBS letters, 1998-07, Vol.431 (3), p.367-370

1998

Volltextzugriff (PDF)

Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain

European journal of biochemistry, 1999-09, Vol.264 (3), p.775-784

1999

Volltextzugriff (PDF)

Localization of surface peptidases

Trends in biochemical sciences (Amsterdam. Regular ed.), 1986-09, Vol.11 (9), p.361-361

1986

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(41)
Animals
(27)
Humans
(22)
Ribosome Inactivating Proteins, Type 2
(19)
Biological And Medical Sciences
(16)
Plant Preparations
(16)
Plant Proteins
(16)
Biochemistry & Molecular Biology
(12)
Male
(12)
Medical Sciences
(12)
Pharmacology & Pharmacy
(12)
Pharmacology. Drug Treatments
(12)
Rats
(12)
Toxins, Biological - Pharmacology
(11)
Cell Line
(10)
Cell Biology
(9)
Female
(9)
Plants, Medicinal
(9)
Cells, Cultured
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group

Weekly 24 h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity

Cisplatin nephrotoxicity and protection by silibinin

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues

Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific Lectin from Viscum album plant extract

Complex regulation of human neutrophil activation by actin filaments: dihydrocytochalasin B and botulinum C2 toxin uncover the existence of multiple cation entry pathways

A phase II multicenter study on CY-503 in the treatment of patients with unresectable stage IV metastatic melanoma after failure of previous chemotherapy

Concanavalin A and mistletoe lectin I differentially activate cation entry and exocytosis in human neutrophils: lectins may activate multiple subtypes of cation channels

A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells

P24. Aviscumine enhances NK- cytotoxicity against tumor cells

Cisplatin nephrotoxicity and protection by silibinin

Site-Specific Mutagenesis of Mistletoe Lectin: The Role of RIP Activity in Apoptosis

Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro

Phase I evaluation of the weekly 24 hour intravenous administration of aviscumine, a recombinant ribosome-inactivating protein, in patients with refractory solid tumors

Phase I evaluation of the weekly 24 hour intravenous administration of aviscumine, a recombinant ribosome-inactivating protein, in patients with refractory solid tumors

Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours

In Vitro Efficacy of Conjugates of Anti-CD45 Monoclonal Antibodies With Plant Toxin A-Chains

Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice

Phagocytotic activity of glial cells in culture

Characterization of recombinant and plant-derived mistletoe lectin and their B-chains

Mistletoe lectin I forms a double trefoil structure

Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain

Localization of surface peptidases

Suchergebnisse filtern